• Biogen Inc.: Needham downgrades to hold from buy.
  • Bright Horizons Family Solutions Inc.: BMO Capital Markets upgrades to outperform from market perform and reduces the target price from USD 137 to USD 125.
  • Cencora, Inc.: Baptista Research downgrades to hold from outperform with a price target raised from USD 261.70 to USD 267.30.
  • Charles River Laboratories International, Inc.: CLSA downgrades to underperform from hold with a target price reduced from USD 205 to USD 164.
  • Cvs Health Corporation: Wells Fargo upgrades to overweight from equalweight with a target price raised from USD 60 to USD 66. 
  • Eog Resources, Inc.: Piper Sandler & Co downgrades to neutral from overweight with a price target raised from USD 147 to USD 149.
  • Hewlett Packard Enterprise Company: Raymond James upgrades to strong buy from outperform with a target price raised from USD 23 to USD 29.
  • Moderna, Inc.: HSBC upgrades to buy from hold with a target price reduced from USD 82 to USD 58.
  • Performance Food Group Company: Baptista Research upgrades to outperform from hold with a price target raised from USD 87.10 to USD 99.
  • Anglo American Plc: SBG Securities (Pty) Ltd upgrades to buy from hold with a target price of GBP 27.
  • Burberry Group Plc: AlphaValue/Baader Europe downgrades to sell from reduce with a price target raised from GBX 761 to GBX 768.
  • Hays Plc: HSBC upgrades to buy from hold with a price target reduced from GBP 1.04 to GBP 1.
  • Shell Plc: Landesbank Baden-Wuerttemberg upgrades to buy from hold with a target price raised from GBX 2800 to GBX 2900.
  • Sthree Plc: HSBC upgrades to buy from hold with a target price reduced from GBP 4.29 to GBP 4.20.
  • Brookfield Asset Management Ltd.: Jefferies remains at hold with a price target raised from USD 43 to USD 52.
  • Canadian Imperial Bank Of Commerce: BMO Capital Markets maintains its outperform rating and raises the target price from 81 to CAD 99.